Attention Deficit Hyperactivity Disorder Market to hit USD 24.6 billion by 2032, says Global Market Insights Inc. [Yahoo! Finance]
Aytu BioPharma, Inc. (AYTU)
NASDAQ:AMEX Investor Relations:
aytubio.com/investors/stock-information
Company Research
Source: Yahoo! Finance
The growth is primarily driven by increasing ADHD diagnoses, advancements in diagnostic tools, and the continuous development of innovative treatments. Rising awareness and understanding of ADHD are also contributing factors, leading to greater demand for enhanced diagnosis and treatment options. Was this helpful? Yes No What is the current market share of stimulants in the ADHD market? Stimulants account for the majority of sales, valued at USD 11.2 billion in 2023. These medications work by increasing norepinephrine and dopamine levels in the brain, helping improve attention, focus, and impulse control. Was this helpful? Yes No Which age group represents the largest share of the ADHD market? Children represent a substantial share of 67.1% in 2023. Early diagnosis and tailored interventions are vital for children with ADHD, helping them address challenges that impact their academic and social development. Was this helpful? Yes No What is the projected siz
Show less
Read more
Impact Snapshot
Event Time:
AYTU
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AYTU alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AYTU alerts
High impacting Aytu BioPharma, Inc. news events
Weekly update
A roundup of the hottest topics
AYTU
News
- Achieve Life Sciences Appoints Mark Oki as Chief Financial Officer [Yahoo! Finance]Yahoo! Finance
- Aytu BioPharma Disclosure Notification [Yahoo! Finance]Yahoo! Finance
- Aytu BioPharma Disclosure NotificationAccesswire
- Aytu BioPharma Ranked as One of Fastest-Growing Companies in North America on the 2024 Deloitte Technology Fast 500(TM) [Yahoo! Finance]Yahoo! Finance
- Aytu BioPharma Ranked as One of Fastest-Growing Companies in North America on the 2024 Deloitte Technology Fast 500(TM)Accesswire
AYTU
Sec Filings
- 12/4/24 - Form 8-K
- 11/13/24 - Form SC
- 11/13/24 - Form 10-Q
- AYTU's page on the SEC website